Assetmark, Inc Gilead Sciences, Inc. Transaction History

Assetmark, Inc

$34.9 Billion
Q3 2024

A detailed history of Assetmark, Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 2,177,364 shares of GILD stock, worth $192 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

2,177,364

Previous 2,068,246 5.28%

Holding current value

$192 Million

Previous $142 Million 28.61%

% of portfolio

0.52%

Previous 0.44%

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$66.59 - $83.99 $7.27 Million - $9.16 Million	109,118 Added 5.28%	2,177,364 $183 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $21.9 Million - $25.3 Million	-346,599 Reduced 14.35%	2,068,246 $142 Million
Q1 2024 May 06, 2024	BUY	$71.58 - $87.29 $1.23 Million - $1.5 Million	17,200 Added 0.72%	2,414,845 $177 Million
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $708,594 - $803,563	-9,671 Reduced 0.4%	2,397,645 $194 Million
Q3 2023 Oct 27, 2023	BUY	$73.94 - $80.67 $20.1 Million - $21.9 Million	271,971 Added 12.74%	2,407,316 $180 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $65.1 Million - $74.2 Million	856,228 Added 66.94%	2,135,345 $165 Million
Q1 2023 May 05, 2023	BUY	$77.31 - $88.08 $2.53 Million - $2.88 Million	32,720 Added 2.63%	1,279,117 $106 Million
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $2.69 Million - $3.86 Million	-43,155 Reduced 3.35%	1,246,397 $107 Million
Q3 2022 Nov 01, 2022	BUY	$59.54 - $68.01 $4.04 Million - $4.62 Million	67,859 Added 5.55%	1,289,552 $79.6 Million
Q2 2022 Aug 03, 2022	SELL	$57.72 - $65.01 $672,957 - $757,951	-11,659 Reduced 0.95%	1,221,693 $75.5 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $37 Million - $46.3 Million	638,450 Added 107.32%	1,233,352 $73.3 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $38.2 Million - $43.3 Million	588,627 Added 9380.51%	594,902 $43.2 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $514,917 - $555,539	-7,607 Reduced 54.8%	6,275 $438,000
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $309,035 - $337,665	-4,869 Reduced 25.97%	13,882 $956,000
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $1.25 Million - $1.42 Million	-20,797 Reduced 52.59%	18,751 $1.21 Million
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $983,444 - $1.12 Million	-17,360 Reduced 30.51%	39,548 $2.3 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $1.72 Million - $2.16 Million	-27,698 Reduced 32.74%	56,908 $3.6 Million
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $3.61 Million - $4.2 Million	49,971 Added 144.28%	84,606 $6.51 Million
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $45,719 - $58,560	-730 Reduced 2.06%	34,635 $2.59 Million
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $28.1 Million - $31 Million	-456,723 Reduced 92.81%	35,365 $2.3 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $5.72 Million - $6.31 Million	91,512 Added 22.85%	492,088 $31.2 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $13.3 Million - $14.9 Million	-214,548 Reduced 34.88%	400,576 $27.1 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $3.59 Million - $4.02 Million	57,456 Added 10.3%	615,124 $40 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $5.84 Million - $7.63 Million	96,531 Added 20.93%	557,668 $34.9 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $892,425 - $988,078	12,520 Added 2.79%	461,137 $35.6 Million
Q2 2018 Aug 01, 2018	BUY	$64.88 - $75.68 $1.08 Million - $1.26 Million	16,610 Added 3.84%	448,617 $31.8 Million
Q1 2018 May 16, 2018	SELL	$72.84 - $88.8 $2.03 Million - $2.47 Million	-27,870 Reduced 6.06%	432,007 $32.6 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $894,995 - $1.05 Million	12,579 Added 2.81%	459,877 $32.9 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $26.5 Million - $31.5 Million	368,182 Added 465.37%	447,298 $36.2 Million
Q2 2017 Aug 15, 2017	BUY	N/A	33,743 Added 74.37%	79,116 $5.6 Million
Q1 2017 Sep 15, 2017	BUY	N/A	35,881 Added 378.01%	45,373 $3.08 Million
Q4 2016 Sep 15, 2017	BUY	N/A	113 Added 1.2%	9,492 $679,000
Q3 2016 Sep 15, 2017	SELL	N/A	-8,987 Reduced 48.93%	9,379 $742,000
Q2 2016 Sep 15, 2017	SELL	N/A	-1,958 Reduced 9.63%	18,366 $1.53 Million
Q1 2016 Sep 15, 2017	BUY	N/A	348 Added 1.74%	20,324 $1.87 Million
Q4 2015 Sep 15, 2017	BUY	N/A	19,976	19,976 $2.02 Million

Others Institutions Holding GILD

# of Institutions

1,917

Shares Held

995M

Call Options Held

10.1M

Put Options Held

9.46M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account